Directors’ Holdings

Member Shares 31/12/2021 Options 31/12/2021
Dr. Gerd Zettlmeissl, Chairman of the Supervisory Board 0 0
Antoinette Hiebeler-Hasner, Deputy Chair of the Supervisory Board 0 0
Prof. Horst Domdey (until 16 December 2020) 39,125 0
Dr. Yita Lee (until 16 December 2020) 0 0
Dr. Anthony Man 0 0
Dr. Keith Manchester1 0 0
Dr. Frank Mathias 20,197 46,0892
Ronald Scott 0 0
Total Supervisory Board 59,322 46,089
Prof. Dr. Dolores J. Schendel, CEO3 846,296 137,500
Dr. Kai Pinkernell, Member of the Executive Management Board (until 31 March 2021) 0 73,438
Axel Sven Malkomes, Member of the Executive Management Board 0 95,000
Total Executive Management Board 846,296 305,938
  1. Dr. Manchester is a partner and Head of Life Sciences QVT Financial LP New York, USA. According to the latest voting rights announcement dated 8 June 2018, the funds managed by QVT hold 1,072,879 shares in Medigene AG.
  2. The stated number of options corresponds to 124,839 options prior to a capital reduction in 2013.
  3. Prof. Schendel indirectly holds 846,296 Medigene shares in her capacity as Managing Director of DJSMontana Holding GmbH, which can be allocated to Prof. Schendel directly.
This site is registered on wpml.org as a development site.